Immunohistological Examination of AKT Isoforms in the Brain: Cell-Type Specificity That May Underlie AKT’s Role in Complex Brain Disorders and Neurological Disease
Cerebral Cortex Communications · 01.04.2021 · 2 (2)
DOI: 10.1093/texcom/tgab036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cerebral Cortex Communications, online erschienen am 28.05.2021. Verfasst von Josien Levenga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO 80303, USA. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS, Linda Crnic Institute.
Abstract (Originalsprache)
Protein kinase B (PKB/AKT) is a central kinase involved in many neurobiological processes. AKT is expressed in the brain as three isoforms, AKT1, AKT2, and AKT3. Previous studies suggest isoform-specific roles in neural function, but very few studies have examined AKT isoform expression at the cellular level. In this study, we use a combination of histology, immunostaining, and genetics to characterize cell-type-specific expression of AKT isoforms in human and mouse brains. In mice, we find that AKT1 is the most broadly expressed isoform, with expression in excitatory neurons and the sole detectable AKT isoform in gamma-aminobutyric acid ergic interneurons and microglia. By contrast, we find that AKT2 is the sole isoform expressed in astroglia and is not detected in other neural cell types. We find that AKT3 is expressed in excitatory neurons with AKT1 but shows greater expression levels in dendritic compartments than AKT1. We extend our analysis to human brain tissues and find similar results. Using genetic deletion approaches, we also find that the cellular determinants restricting AKT isoform expression to specific cell types remain intact under Akt deficiency conditions. Because AKT signaling is linked to numerous neurological disorders, a greater understanding of cell-specific isoform expression could improve treatment strategies involving AKT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO 80303, USA.
- Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80303, USA.
- Linda Crnic Institute, Anschutz Medical Campus, Aurora, CO 80045, USA.
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- Linda Crnic Institute
- National Institutes of Health
Zitieren
APA
Levenga, J., Wong, H., Milstead, R., LaPlante, L., & Hoeffer, C. A. (2021). Immunohistological Examination of AKT Isoforms in the Brain: Cell-Type Specificity That May Underlie AKT’s Role in Complex Brain Disorders and Neurological Disease. Cerebral Cortex Communications, 2(2). https://doi.org/10.1093/texcom/tgab036
Vancouver
Levenga J, Wong H, Milstead R, LaPlante L, Hoeffer CA. Immunohistological Examination of AKT Isoforms in the Brain: Cell-Type Specificity That May Underlie AKT’s Role in Complex Brain Disorders and Neurological Disease. Cerebral Cortex Communications. 2021;2(2). doi:10.1093/texcom/tgab036
BibTeX
@article{Levenga2021,
author = {Levenga, Josien and Wong, Helen and Milstead, Ryan and LaPlante, Lauren and Hoeffer, Charles A},
title = {Immunohistological Examination of AKT Isoforms in the Brain: Cell-Type Specificity That May Underlie AKT’s Role in Complex Brain Disorders and Neurological Disease},
journal = {Cerebral Cortex Communications},
year = {2021},
volume = {2},
number = {2},
doi = {10.1093/texcom/tgab036}
}
EUVIMED